|
1
|
Kamisawa T, Zen Y, Pillai S and Stone JH:
IgG4-related disease. Lancet. 385:1460–1471. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wallace ZS, Naden RP, Chari S, Choi H,
Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi
A, et al: The 2019 American college of rheumatology/european league
against rheumatism classification criteria for IgG4-related
disease. Ann Rheum Dis. 79:77–87. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kamisawa T, Funata N, Hayashi Y, Eishi Y,
Koike M, Tsuruta K, Okamoto A, Egawa N and Nakajima H: A new
clinicopathological entity of IgG4-related autoimmune disease. J
Gastroenterol. 38:982–984. 2003.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Okazaki K, Uchida K, Koyabu M, Miyoshi H,
Ikeura T and Takaoka M: IgG4 cholangiopathy: Current concept,
diagnosis, and pathogenesis. J Hepatol. 61:690–695. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Masamune A, Kikuta K, Hamada S, Tsuji I,
Takeyama Y, Shimosegawa T and Okazaki K: Collaborators. Nationwide
epidemiological survey of autoimmune pancreatitis in Japan in 2016.
J Gastroenterol. 55:462–470. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lanzillotta M, Mancuso G and Della-Torre
E: Advances in the diagnosis and management of IgG4 related
disease. BMJ. 369(m1067)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pan YY, Zhou SC, Wang YJ, Zhu TT, Peng D
and Guan HX: IgG4-related disease: A retrospective Chinese study of
features and treatment response of 98 patients including 4 rare
cases. Curr Med Sci. 41:390–397. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ebbo M, Daniel L, Pavic M, Sève P, Hamidou
M, Andres E, Burtey S, Chiche L, Serratrice J, Longy-Boursier M, et
al: IgG4-related systemic disease: Features and treatment response
in a French cohort: Results of a multicenter registry. Medicine
(Baltimore). 91:49–56. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Inoue D, Yoshida K, Yoneda N, Ozaki K,
Matsubara T, Nagai K, Okumura K, Toshima F, Toyama J, Minami T, et
al: IgG4-related disease: Dataset of 235 consecutive patients.
Medicine (Baltimore). 94(e680)2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yamada K, Yamamoto M, Saeki T, Mizushima
I, Matsui S, Fujisawa Y, Hara S, Takahashi H, Nomura H, Kawa S and
Kawano M: New clues to the nature of immunoglobulin G4-related
disease: A retrospective Japanese multicenter study of baseline
clinical features of 334 cases. Arthritis Res Ther.
19(262)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu Y, Zhu L, Wang Z, Zeng Q, Yang F, Gao
J, Wang Z, Wang K, Ren L, Zhang Y, et al: Clinical features of
IgG4-related retroperitoneal fibrosis among 407 patients with
IgG4-related disease: A retrospective study. Rheumatology (Oxford).
60:767–772. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Moriarty MA, Dahmoush L and Nepple KG:
IgG4 related disease of the ureter (inflammatory pseudotumor). J
Urol. 191:1126–1127. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Marando A, D'Ambrosio G, Catanzaro F, La
Rosa S and Sessa F: IgG4-related disease of the ureter: Report of
two cases and review of the literature. Virchows Arch. 462:673–678.
2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fernández-Codina A, Pinilla B,
Pinal-Fernández I, López C, Fraile-Rodríguez G, Fonseca-Aizpuru E,
Carballo I, Brito-Zerón P, Feijóo-Massó C, López-Dupla M, et al:
Treatment and outcomes in patients with IgG4-related disease using
the IgG4 responder index. Joint Bone Spine. 85:721–726.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Dai T and He YQ: CT and MRI features of
multi-organ involvement in IgG4-related disease. Diagn Interv
Imaging. 104:261–262. 2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Vaglio A, Catanoso MG, Spaggiari L,
Magnani L, Pipitone N, Macchioni P, Pulsatelli L, Nicastro M,
Becchi G, Corradi D, et al: Interleukin-6 as an inflammatory
mediator and target of therapy in chronic periaortitis. Arthritis
Rheum. 65:2469–2475. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Adding Ref, Arora K, Rivera M, Ting DT and
Deshpande V: The histological diagnosis of IgG4-related disease on
small biopsies: challenges and pitfalls. Histopathology.
74:688–698. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lecler A and Sene T: MRI and
ultrasonography are useful tools for a non-invasive diagnosis of
IgG4-related disease. Ann Rheum Dis. 81(e51)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Raglianti V, Rossi GM and Vaglio A:
Idiopathic retroperitoneal fibrosis: An update for nephrologists.
Nephrol Dial Transplant. 36:1773–1781. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bakir B, Yilmaz F, Turkay R, Ozel S,
Bilgiç B, Velioglu A, Saka B and Salmaslioglu A: Role of
diffusion-weighted MR imaging in the differentiation of benign
retroperitoneal fibrosis from malignant neoplasm: Preliminary
study. Radiology. 272:438–445. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Abe H, Morikawa T, Araki A, Shima T,
Nakatsu H, Fukayama M and Suzuki Y: IgG4-related periureteral
fibrosis presenting as a unilateral ureteral mass. Pathol Res
Pract. 207:712–714. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kawano M, Saeki T and Nakashima H:
IgG4-related kidney disease and retroperitoneal fibrosis: An
update. Mod Rheumatol. 29:231–239. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lei WH, Xin J, Shao CX, Mao MF, Zhu CY, Wu
CF and Jin L: IgG4-related kidney disease mimicking malignant
ureter tumor: Case report and literature review. Medicine
(Baltimore). 95(e2550)2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Improta L, Tzanis D, Bouhadiba T,
Abdelhafidh K and Bonvalot S: Overview of primary adult
retroperitoneal tumours. Eur J Surg Oncol. 46:1573–1579.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Katz G and Stone JH: Clinical perspectives
on IgG4-related disease and its classification. Annu Rev Med.
73:545–562. 2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Carruthers MN, Topazian MD, Khosroshahi A,
Witzig TE, Wallace ZS, Hart PA, Deshpande V, Smyrk TC, Chari S and
Stone JH: Rituximab for IgG4-related disease: A prospective,
open-label trial. Ann Rheum Dis. 74:1171–1177. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Miki M, Fujimori N, Oono T, Kawabe K, Ohno
A, Matsumoto K, Teramatsu K, Tachibana Y and Ogawa Y: Relapse
patterns and predictors of IgG4-related diseases involved with
autoimmune pancreatitis: A single-center retrospective study of 115
patients. J Dig Dis. 20:152–158. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu Y, Zeng Q, Zhu L, Gao J, Wang Z, Wang
Z, Yang F, Wang K, Chen D, Xia C, et al: Relapse predictors and
serologically unstable condition of IgG4-related disease: A large
Chinese cohort. Rheumatology (Oxford). 59:2115–2123.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Peng Y, Li JQ, Zhang PP, Zhang X, Peng LY,
Chen H, Zhou JX, Zhang SZ, Yang HX, Liu JJ, et al: Clinical
outcomes and predictive relapse factors of IgG4-related disease
following treatment: A long-term cohort study. J Intern Med.
286:542–552. 2019.PubMed/NCBI View Article : Google Scholar
|
